Home › Compare › GENX vs MO

GENX vs MO: Dividend Comparison 2026

GENX yields 1000000.00% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GENX wins by $4.7683925249533696e+36M in total portfolio value
10 years
GENX
GENX
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full GENX calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — GENX vs MO

📍 GENX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGENXMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GENX + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GENX pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GENX
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, GENX beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GENX + MO for your $10,000?

GENX: 50%MO: 50%
100% MO50/50100% GENX
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

GENX
No analyst data
Altman Z
0.9
Piotroski
4/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GENX buys
0
MO buys
0
No recent congressional trades found for GENX or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGENXMO
Forward yield1000000.00% ✓6.27%
Annual dividend / share$2.00$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6% ✓
Portfolio after 10y$4.7683925249533696e+36M$77.7K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$28,968.54
Total dividends collected$4.7683311610149396e+36M$72.0K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GENX vs MO ($10,000, DRIP)

YearGENX PortfolioGENX Income/yrMO PortfolioMO Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,558$768.31+$100.00M → GENX
2$934,786,450,701$934,679,439,252.34$11,352$1,015.87+$934786.44M → GENX
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,482$1,367.86+$8165787108.57M → GENX
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$14,103$1,883.39+$66665884190957.63M → GENX
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$16,472$2,664.91+$508662171058048128.00M → GENX
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$20,024$3,897.79+$3.62723524842849e+21M → GENX
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$25,537$5,933.74+$2.417368115915061e+25M → GENX
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$34,478$9,476.77+$1.5056740286145463e+29M → GENX
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$49,776$16,022.63+$8.764771002818475e+32M → GENX
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$77,699$28,968.54+$4.7683925249533696e+36M → GENX

GENX vs MO: Complete Analysis 2026

GENX — Stock

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.

Full GENX Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this GENX vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GENX vs SCHDGENX vs JEPIGENX vs OGENX vs KOGENX vs MAINGENX vs PMGENX vs BTIGENX vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.